Escherichia coli ATCC 35218 as a quality control isolate for susceptibility testing of Haemophilus influenzae with haemophilus test medium

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 2, 1999, Pages 283-286

  Butler, D L ^a,b   Jakielaszek, C J ^a   Miller, L A ^a   Poupard, J A ^a  

^a SmithKline Beecham Pharmaceutical ^*  (United States)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; CLAVULANIC ACID; PIPERACILLIN; SULBACTAM; TAZOBACTAM;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; ESCHERICHIA COLI; HAEMOPHILUS INFLUENZAE; NONHUMAN; PRIORITY JOURNAL; QUALITY CONTROL;

EID: 0032990770     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.2.283     Document Type: Article

References (10)

1. Cooper, C. E., B. Slocombe, and A. R. White. 1990. Effect of low concentrations of clavulanic acid on the in-vitro activity of amoxicillin against β-lactamase-producing Branhamella catarrhalis and Haemophilus influenzae. J. Antimicrob. Chemother. 26:371-380.
2. Doern, G. V., A. B. Brueggemann, G. Pierce, H. P. Holley, Jr., and A. Rauch. 1997. Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of β-lactamase-positive strains resistant to amoxicillin-clavulanate: results of a national multicenter surveillance study. Antimicrob. Agents Chemother. 41:292-297.
3. Doern, G. V., and The Alexander Project Collaborative Group. 1996. Antimicrobial resistance among lower respiratory tract isolates of Haemophilus influenzae: results of a 1992-93 Western Europe and USA collaborative surveillance study. J. Antimicrob. Chemother. 38(Suppl. A.):59-69.
4. Jacobs, M. R., S. Bajaksouzian, G. Lin, and P. C. Appelbaum. 1998. Susceptibility of Streptococcus pneumoniae and Haemophilus influenzae to oral agents: results of a 1997 epidemiological survey, abstr. A-31, p. 43. In abstracts of the 98th General Meeting of the American Society for Microbiology 1998. American Society for Microbiology, Washington, D.C.
5. National Committee for Clinical Laboratory Standards. 1983. Performance standards for antimicrobial disk susceptibility tests. NCCLS publication no. M2-A3. National Committee for Clinical Laboratory Standards, Wayne, Pa.
6. National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. NCCLS publication no. M7-A4. National Committee for Clinical Laboratory Standards, Wayne, Pa.
7. National Committee for Clinical Laboratory Standards. 1997. Performance standards for antimicrobial disk susceptibility tests. NCCLS publication no. M2-A6. National Committee for Clinical Laboratory Standards, Wayne, Pa.
8. Richard, M. P., A. Gil Aguado, R. Mattina, R. Marre, and the SPAR Study Group. 1998. Sensitivity to sparfloxacin and other antibiotics, of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis strains isolated from adult patients with community-acquired lower respiratory tract infections: a European multicentre study. J. Antimicrob. Chemother. 41: 207-214.
9. Schito, G. C., S. Mannelli, A. Pesce, and The Alexander Project Group. 1997. Trends in the activity of macrolide and β-lactam antibiotics and resistance development. J. Chemother. 9(Suppl. 3.):18-27.
10. Thornsberry, C., P. Ogilvie, J. Kahn, Y. Mauriz, and the Laboratory Investigator Group. 1997. Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996-1997 respiratory season. Diagn. Microbiol. Infect. Dis. 29: 249-257.